Press release
16.02.2021 To the attention of interested persons EMA press release: Review of amfepramone medicines started download document …
Important notification
15.02.2021 To the attention of marketing authorisation holders Request for assessment of the risk of the presence of nitrosamine impurities […]
Press release
12.02.2021 To the attention of interested persons EMA press release: EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV) download […]
Press release
11.02.2021 To the attention of interested persons EMA press release: Clarification on Sputnik V vaccine in the EU approval process […]
Press release
08.02.2021 To the attention of interested persons EMA press release: EMA reviewing data on monoclonal antibody use for COVID-19 download […]
Press release
08.02.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca download document …
Press release
05.02.2021 To the attention of interested persons EMA press release: EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU […]
Press release
05.02.2021 To the attention of interested persons EMA press release: EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373) download […]
Important notification
04.02.2021 To the attention of interested persons In order to deal with the consequences described in the opinion issued by […]
Important notification
04.02.2021 To the attention of interested persons Commission Notice – Application of the Union’s pharmaceutical acquis in markets historically dependent […]